Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress. Read more about Cytosine-based nucleoside analogs are selectively lethal to DNA mismatch repair-deficient tumour cells by enhancing levels of intracellular oxidative stress.
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Read more about Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Read more about Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. Read more about A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer.
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. Read more about Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Read more about Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Read more about The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology.
Oncogenic AKTivation of translation as a therapeutic target. Read more about Oncogenic AKTivation of translation as a therapeutic target.
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Read more about Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.
Molecular alterations associated with liver metastases development in colorectal cancer patients. Read more about Molecular alterations associated with liver metastases development in colorectal cancer patients.
